Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 6/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7019557 | 1.00 | APP (0.57) | APPTDP1KDM4ERECQLTSHR | |
| SCHEMBL3021121 | 1.00 | APP (0.57) | APPTDP1KDM4ERECQLTSHR | |
| SCHEMBL16758740 | 1.00 | APP (0.57) | APPTDP1KDM4ERECQLTSHR | |
| SCHEMBL5357 | 0.94 | TDP1 (0.59) | APPTDP1KDM4ERECQLTSHR | |
| SCHEMBL15814832 | 0.92 | APP (0.50) | APPTDP1KDM4ERECQLTSHR | |
| SCHEMBL15071342 | 0.89 | APP (0.67) | APPTDP1KDM4ETSHRNPC1 | |
| SCHEMBL3611926 | 0.89 | KDM4E (0.61) | APPTDP1KDM4ERECQLMAPK1 | |
| SCHEMBL12703538 | 0.89 | KDM4E (0.61) | APPTDP1KDM4ERECQLMAPK1 | |
| SCHEMBL1353069 | 0.89 | APP (0.67) | APPTDP1KDM4ETSHRNPC1 | |
| SCHEMBL7911522 | 0.89 | APP (0.67) | APPTDP1KDM4ETSHRNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543856-A1 | BENZOCARBAZOLE DERIVATIVES AS INHIBITORS OF DRP1 | Asha Therapeutics LLC (US) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023249965-A1 | BENZOCARBAZOLE DERIVATIVES AS INHIBITORS OF DRP1 | ASHA THERAPEUTICS LLC (US) | 2023-12-28 | — | — | WO | disclosed |
| EP-3173414-A1 | HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS | ACEA Biosciences Inc. (US) | 2017-05-31 | — | — | EP | disclosed |
| US-9645153-B2 | Labeling reagents and methods of their use | Life Technologies Corporation (US) | 2017-05-09 | — | — | US | disclosed |
| US-9645153-B2 | Labeling reagents and methods of their use | Life Technologies Corporation (US) | 2017-05-09 | — | — | US | disclosed |
| US-9645153-B2 | Labeling reagents and methods of their use | Life Technologies Corporation (US) | 2017-05-09 | — | — | US | disclosed |
| EP-2188271-B1 | HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS | ACEA BIOSCIENCES INC (US) | 2017-01-11 | — | — | EP | disclosed |
| US-20160046576-A1 | NOVEL PYRROLE DERIVATIVES | UNIV LEICESTER (GB) | 2016-02-18 | — | — | US | disclosed |
| US-20150355186-A1 | Labeling Reagents and Methods of Their Use | INVITROGEN CORPORATION | 2015-12-10 | — | — | US | disclosed |
| US-20150355186-A1 | Labeling Reagents and Methods of Their Use | INVITROGEN CORPORATION | 2015-12-10 | — | — | US | disclosed |
| US-20090004753-A1 | LABELING REAGENTS AND METHODS OF THEIR USE | INVITROGEN CORPORATION (US) | 2009-01-01 | — | — | US | disclosed |
| US-20090004753-A1 | LABELING REAGENTS AND METHODS OF THEIR USE | INVITROGEN CORPORATION (US) | 2009-01-01 | — | — | US | disclosed |
| US-7459137-B2 | Process for functionalizing carbon nanotubes under solvent-free conditions | WILLIAM MARSH RICE UNIVERSITY (US) | 2008-12-02 | — | — | US | disclosed |
| US-7384815-B2 | One step; high functionality; maintains critical properties; polymer composite materials, molecular electronics, sensor devices | WILLIAM MARSH RICE UNIVERSITY (US) | 2008-06-10 | — | — | US | disclosed |
| US-7250147-B2 | One step; high functionality; maintains critical properties; polymer composite materials, molecular electronics, sensor devices | NAVY, SECRETARY OF THE UNITED STATES OF AMERICA | 2007-07-31 | — | — | US | disclosed |
| EP-1778700-A1 | SYNTHETICALLY EXPEDIENT WATER-DISPERSIBLE IR DYES | Silverbrook Research Pty. Ltd (AU) | 2007-05-02 | — | — | EP | disclosed |
| US-20060272545-A1 | Inkjet lnks for printing coded data comprising naphthalocyanine dyes | SILVERBROOK RESEARCH PTY LTD | 2006-12-07 | — | — | US | disclosed |
| US-7122076-B2 | Synthetically expedient water-dispersible IR dyes | SILVERBROOK RESEARCH PTY LTD (AU) | 2006-10-17 | — | — | US | disclosed |
| WO-2006015414-A1 | SYNTHETICALLY EXPEDIENT WATER-DISPERSIBLE IR DYES | SILVERBROOK RESEARCH PTY LTD (AU) | 2006-02-16 | — | — | WO | disclosed |
| US-20060030706-A1 | Synthetically expedient water-dispersible IR dyes | SILVERBROOK RESEARCH PTY LTD | 2006-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150355186-A1 | Labeling Reagents and Methods of Their Use | GUSB, CES2, MRPL21 | APP 4167/4885TDP1 2001/4885KDM4E 3693/4885 |
| US-20160046576-A1 | NOVEL PYRROLE DERIVATIVES | PYCR1, ARG1, PNISR | APP 2881/4885TDP1 971/4885KDM4E 1392/4885 |
| US-20060030706-A1 | Synthetically expedient water-dispersible IR dyes | SLC39A11, SLC13A3, SLC39A3 | APP 4746/4885TDP1 1869/4885KDM4E 4645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.